SCHEMBL960656

SCHEMBL960656

COc1cccc(CCOc2cccc(-c3cccc(C(=O)Nc4nccs4)c3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.53
NPC1 O15118 7/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
HPGD P15428 3/20 0.53
SIRT2 Q8IXJ6 1/20 0.52
GPR52 Q9Y2T5 2/20 0.49
ALDH1A1 P00352 3/20 0.48
MAPT P10636 2/20 0.48
HPGDS O60760 1/20 0.48
THRB P10828 1/20 0.48
MAPK1 P28482 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
USP2 O75604 1/20 0.46
HTT P42858 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP3A4 P08684 1/20 0.45
ABL1 P00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12919107 0.89 SMN1; SMN2 (0.57) RAB9ANPC1SMN1; SMN2HPGDSIRT2
SCHEMBL960541 0.88 GPR52 (0.54) RAB9ANPC1SMN1; SMN2HPGDSIRT2
SCHEMBL961649 0.87 GPR52 (0.49) RAB9ANPC1SMN1; SMN2HPGDGPR52
SCHEMBL958255 0.84 GPR52 (0.56) HPGDGPR52MAPTLMNAAURKA
SCHEMBL959928 0.84 SIRT2 (0.52) SIRT2GPR52AURKA
SCHEMBL963749 0.83 GPR52 (0.49) RAB9ANPC1SMN1; SMN2HPGDGPR52
SCHEMBL959963 0.82 GPR52 (0.49) RAB9ANPC1SMN1; SMN2HPGDGPR52
SCHEMBL961206 0.82 GPR52 (0.63) RAB9ANPC1SMN1; SMN2HPGDGPR52
SCHEMBL961439 0.81 GPR52 (0.52) RAB9ASMN1; SMN2GPR52AURKA
SCHEMBL959859 0.81 GPR52 (0.73) RAB9ANPC1GPR52ALDH1A1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 RAB9A 1785/4885NPC1 2153/4885SMN1; SMN2 3368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.